6533b851fe1ef96bd12a9008
RESEARCH PRODUCT
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.
Silvano PifferKamila KepskaK. HenauBénédicte Lapôtre-ledouxMaja Primic-zakeljAnna GavinAnselmo MadedduNeville CallejaFabio PannozzoM UsalaMarc ColonnaMarià CarullaDyfed Wyn HuwsJon G. JonassonXavier TroussardAntonio ZiinoSilvia RossiVitale FrancescoConchi Moreno-iribasRiccardo CapocacciaAdriano GiacominIsabelle KonzelmannJ. BłaszczykClaire SchvartzAnne-marie BouvierMohsen MousaviAnne-valérie GuizardChakameh Safaei DibaMaarit K. LeinonenLaura BottaNadya DimitrovaDiego SerrainoArantza Lopez De MunainGemma GattaAnne-sophie WoronoffElizabeth Van EyckenL BenfattoE MaraniNea MalilaLadislav DušekMariano SantaquilaniHarry ComberArturo IannelliJosé María Díaz GarcíaMaria José BentoM. RobaszkiewiczStanisław GóźdźM.a. GentiliniStefano FerrettiAna MirandaAndrea TavillaPaolo RicciSilvia EssDiego SalmerónM AutelitanoCarmen NavarroAlessandro BarchielliDaniela PierannunzioGianbattista SpagnoliGiedre SmailyteSanta PildavaRoland StabenowNerea LarrañagaArnold KnijnSimona BaraFlavio SensiNicolas GirardNicolas GirardAlice NenneckeFabrizio StracciGiovanna TagliabueAna Torrella-ramosMassimo RuggeBernd HolleczekAndrea BordoniMichel VeltenRosario TuminoDavid BrewsterJadwiga RachtanAlain MonnereauM. SekerijaJan HeidrichSabine LuttmannKerri Clough-gorrChristine BouchardyVéronique BouvierValerio GennaroRosa FilibertiLucia MangonePatrick ArveuxBrigitte TrétarreIsabelle BaldiRoberta De AngelisMartina ImbimboMargit MägiMarc MaynadiéJutta EngelGuido MazzoleniOtto VisserMaría José SánchezJean-michel MauryMarina Chiara GarassinoRafael Marcos-grageraE. AlmarGabriele Schubert-fritschleSandra MalloneJaume GalceranPascale GrosclaudeS MasperoJem RashbassTom Børge JohannesenGonçalo Forjaz De LacerdaMaria MichiaraMagdalena Bielska-lasotaEllen BenhamouAnnalisa TramaFlorence MoliniéPina CandelaMonika HacklFabio FalciniIan KunklerAntonella Sutera SardoMario Fuscosubject
0301 basic medicineMesotheliomamedicine.medical_specialtyInternational CooperationPleural NeoplasmsMEDLINESocio-culturaleContext (language use)Translational researchDiseaseSocial Networking03 medical and health sciences0302 clinical medicineMultidisciplinary approachMedicineHumansMesotheliomaPleural NeoplasmIntensive care medicinebusiness.industryGeneral MedicineThymus Neoplasmsmedicine.diseaseClinical trialEuropeSurvival Rate030104 developmental biologyClinical researchOncology030220 oncology & carcinogenesisSurgery; OncologySurgerybusinessDelivery of Health Caremesothelioma thymic tumours clinical trialsHumandescription
The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of databases, translational research programs, and clinical trials. Access to innovative strategies represents a major challenge, as there is a lack of funding for clinical research in rare cancers and their rarity precludes the design of robust clinical trials that could lead to specific approval of drugs. In this context, patient-centered initiatives, such as the establishment of dedicated networks, are warranted. International societies, such as IMIG (International Mesothelioma Interest Group) and ITMIG (International Thymic Malignancy Interest Group) provide infrastructure for global collaboration, and there are many advantages to having strong regional groups working on the same issues. There may be regional differences in risk factors, susceptibility, management and outcomes. The ability to address questions both regionally as well as globally is ideal to develop a full understanding of mesothelioma and thymic malignancies. In Europe, through the integration of national networks with EURACAN, the collaboration with academic societies and international groups, the development of networks in thoracic oncology provides multiplex integration of clinical care and research, ultimately ensuring equal access to high quality care to all patients, with the opportunity of conducting high level clinical and translational research projects.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2017-10-25 | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology |